Future Virology

Scope & Guideline

Exploring Tomorrow's Discoveries in Virology

Introduction

Welcome to your portal for understanding Future Virology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1746-0794
PublisherFUTURE MEDICINE LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2007 to 2024
AbbreviationFUTURE VIROL / Future Virol.
Frequency18 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND

Aims and Scopes

Future Virology aims to advance the understanding of viral diseases through comprehensive research, innovative methodologies, and interdisciplinary approaches. The journal encompasses a diverse range of topics within virology, focusing on both fundamental research and applied science.
  1. Antiviral Research and Development:
    The journal emphasizes the development of novel antiviral agents, therapies, and treatment strategies for various viral infections, including emerging and re-emerging viruses.
  2. Viral Pathogenesis and Host Interaction:
    Investigation into the mechanisms of viral infection, replication, and pathogenesis, alongside the host's immune response and genetic factors influencing susceptibility and disease outcomes.
  3. Clinical Virology and Epidemiology:
    Research on the clinical aspects of viral infections, including epidemiological studies, diagnostics, treatment outcomes, and public health implications.
  4. Innovative Diagnostic Techniques:
    Development and assessment of new diagnostic tools and methodologies for the detection and monitoring of viral infections.
  5. Vaccine Development and Immunization Strategies:
    Exploration of vaccine efficacy, safety, and development strategies for various viral pathogens, with a focus on innovative approaches and technologies.
  6. Emerging Viral Threats and One Health Perspectives:
    Addressing the public health implications of emerging viruses, zoonotic diseases, and the interconnectedness of human, animal, and environmental health.
Future Virology is witnessing significant growth in several emerging themes, reflecting the evolving landscape of viral research and the urgent need for innovative solutions in virology.
  1. COVID-19 Research and Long-Term Effects:
    The ongoing research surrounding COVID-19, including long-term health impacts, vaccine efficacy, and therapeutic options, remains a dominant theme as the pandemic continues to evolve.
  2. Innovative Therapeutics and Drug Repurposing:
    There is an increased emphasis on the discovery and application of novel antiviral therapies, including drug repurposing strategies, particularly in response to the COVID-19 pandemic.
  3. Genomic and Molecular Epidemiology:
    Research focusing on the genomic characterization of viral pathogens and the epidemiological dynamics of viral spread is gaining traction, providing insights into transmission patterns and mutation rates.
  4. Viral Immunology and Host Interaction Studies:
    Emerging interest in understanding the complex interactions between viruses and host immune responses, including the role of host genetics in disease susceptibility.
  5. Nanotechnology and Advanced Delivery Systems:
    Exploration of nanotechnology applications in virology, particularly in drug delivery systems and vaccine development, is becoming increasingly relevant.
  6. Public Health and Policy Implications of Viral Diseases:
    Research addressing the broader implications of viral diseases on public health policy, vaccine distribution, and community health strategies is emerging as a critical area of focus.

Declining or Waning

While Future Virology continues to explore a wide array of topics, certain themes appear to be on the decline based on recent publication trends. These waning scopes may reflect shifts in research focus or advancements in understanding that render previous topics less prominent.
  1. Traditional Antiviral Agents:
    Research on older antiviral agents is becoming less frequent as newer therapies and innovative approaches gain traction. The focus is shifting towards developing novel compounds and therapeutic strategies.
  2. Viral Infections in Non-Human Hosts:
    Studies specifically targeting viral infections in animal models or non-human hosts have seen a decline, possibly as focus moves towards human-related health issues and zoonotic risks.
  3. Basic Virology Studies:
    There is a noticeable decrease in purely basic virology research that does not directly relate to clinical applications or emerging threats, as the journal aims to maintain a practical relevance.
  4. Viral Infections in Specific Populations:
    Research focusing solely on niche populations or specific demographics, such as rare infections in isolated communities, is less prevalent, indicating a broader focus on more generalizable findings.

Similar Journals

JOURNAL OF CLINICAL VIROLOGY

Transforming Knowledge into Solutions for Viral Challenges
Publisher: ELSEVIERISSN: 1386-6532Frequency: 12 issues/year

Journal of Clinical Virology, published by Elsevier, stands at the forefront of virology research, focusing on the clinical implications of viral diseases. With an impressive impact factor representative of its Q1 categorization in both Infectious Diseases and Virology, this journal is essential for researchers and healthcare professionals aiming to keep pace with evolving knowledge and treatments in virology. Since its inception in 1998, it has provided a vital platform for the dissemination of significant breakthroughs, now continuing through to 2024. The journal boasts competitive Scopus ranks, placing it in the 95th percentile for Infectious Diseases and the 91st percentile for Virology. Scholars can benefit from its selective Open Access options, promoting widespread access to cutting-edge research. With an ever-increasing demand for innovative solutions to viral infections, Journal of Clinical Virology remains dedicated to fostering advancements in the field, making it a key resource for anyone invested in virology and infectious disease management.

VIROLOGIE

Innovating insights in virology and treatment.
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 1267-8694Frequency: 6 issues/year

VIROLOGIE is a prominent international journal dedicated to advancing the field of virology and infectious diseases, published by John Libbey Eurotext Ltd. Since its inception in 1997, this journal has provided a platform for researchers and professionals to disseminate their findings on various aspects of virology, including the pathogenesis, epidemiology, and treatment of viral infections. Despite its current ranking in Q4 for both Infectious Diseases and Virology categories, the journal remains a valuable resource for emerging research and novel insights. The ISSN for the journal is 1267-8694, and it is based in France. VIROLOGIE is committed to upholding rigorous academic standards and fosters an inclusive scholarly community, making it an essential read for those pursuing knowledge and advancements in the ever-evolving landscape of virology. While the journal does not currently offer open access options, it continues to contribute significantly to the global discourse on viral research through its diverse range of published studies.

REVIEWS IN MEDICAL VIROLOGY

Advancing the Frontiers of Virology Research
Publisher: WILEYISSN: 1052-9276Frequency: 6 issues/year

REVIEWS IN MEDICAL VIROLOGY is a premier academic journal published by Wiley, dedicated to advancing the field of virology and infectious diseases. Established in 1991, this journal has gained a reputable standing, holding a Q1 ranking in both Infectious Diseases and Virology as of 2023, with impressive Scopus rankings placing it at #17 out of 344 in the realm of Medicine - Infectious Diseases, and #8 out of 80 in Immunology and Microbiology - Virology. This reflects its substantial impact factor and contribution to ongoing research and scholarship. While it is not an Open Access publication, REVIEWS IN MEDICAL VIROLOGY offers vital insights and comprehensive reviews that cater to a diverse audience including researchers, healthcare professionals, and students pursuing knowledge in medical virology. The journal serves as a vital resource for understanding the complexities of viral pathogens and the evolving landscape of antiviral therapeutics, making it an essential read for those poised at the forefront of infectious disease research.

ARCHIVES OF VIROLOGY

Advancing knowledge in viral research.
Publisher: SPRINGER WIENISSN: 0304-8608Frequency: 12 issues/year

Archives of Virology is a prestigious academic journal dedicated to the field of virology, published by Springer Wien. Established in 1975, this journal has been a crucial platform for disseminating innovative research findings and advancements in the understanding of viral diseases and their impact on human health. It holds a notable position in the academic landscape, with a 2023 impact factor placing it in Q2 within the field of Medicine (miscellaneous) and Q3 in Virology. Its Scopus ranking within the Virology category further underscores its relevance, with a notable percentile of 45th. Although it does not provide Open Access options, the journal's rigorous peer-review process ensures the highest quality of published work, making it an essential resource for researchers, professionals, and students aiming to stay updated in the rapidly evolving field of virology. For those committed to advancing their understanding of viruses and viral diseases, Archives of Virology is a vital scholarly resource.

Journal of Virology

Unraveling the Mysteries of Virology
Publisher: AMER SOC MICROBIOLOGYISSN: 0022-538XFrequency: 12 issues/year

Journal of Virology is a premier scholarly journal dedicated to advancing the field of virology, focusing on the molecular mechanisms of virus-host interactions, viral pathogenesis, and the latest therapeutic and vaccine developments. Published by the American Society for Microbiology, this esteemed journal has been a cornerstone for researchers since its inception in 1967, providing a platform for high-quality, peer-reviewed research. With a commendable impact factor indicative of its relevance and influence, the journal is categorized in the top quartile (Q1) for Virology, Microbiology, and Insect Science, reflecting its significance in these fields. Researchers can access a wealth of studies and findings that shape our understanding of viruses and their interactions with hosts, highlighting its role in both basic and applied sciences. Positioned in the United States, the Journal of Virology serves a global audience, ensuring that cutting-edge discoveries reach professionals, students, and academics alike. Join the conversation as we explore the complexities of virology and its implications for human health and disease.

Current Opinion in Virology

Navigating the Evolving Landscape of Virology
Publisher: ELSEVIER SCI LTDISSN: 1879-6257Frequency: 6 issues/year

Current Opinion in Virology, published by Elsevier Science Ltd, is a premier journal dedicated to advancing knowledge in the dynamic field of virology. Established as a respected source of comprehensive reviews and critical evaluations, this journal boasts an impressive impact factor and has achieved a distinguished Q1 category ranking for virology, signifying its pivotal role in the academic community. Serving researchers, professionals, and students alike, Current Opinion in Virology presents insightful contributions that delve into the latest developments, emerging trends, and pivotal challenges facing virology today. With its Scopus ranking placing it in the top 15% of its field, the journal provides unparalleled access to cutting-edge research that informs both basic and applied aspects of virology. Although not an open-access journal, it offers options for subscriptions that ensure accessibility to critical content. As the field continuously evolves, Current Opinion in Virology remains at the forefront, bridging the gap between research and clinical application, making it an essential resource for all in the virology community.

Viruses-Basel

Leading the Charge in Virology Innovation
Publisher: MDPIISSN: Frequency: 12 issues/year

Viruses-Basel, published by MDPI, is a leading interdisciplinary journal focused on the field of virology and infectious diseases, offering a platform for the rapid dissemination of high-quality research. Established in 2009, this open access journal has become an essential resource for researchers and health professionals, ensuring that critical findings are readily available to a global audience. With an impressive Q1 ranking in Infectious Diseases and a Q2 ranking in Virology as of 2023, the journal reflects its commitment to impactful research, validated by its notable positions within Scopus categories—ranked #84 out of 344 in Medicine: Infectious Diseases and #27 out of 80 in Immunology and Microbiology: Virology. The journal adheres to high standards of academic rigor, and by embracing an open access model, it promotes unrestricted access to scientific knowledge, fostering collaboration among researchers, professionals, and students alike. Situated in Basel, Switzerland, the journal serves as a cornerstone in the dissemination of research findings related to viral diseases and their implications on public health.

CURRENT HIV RESEARCH

Pioneering Insights for a Healthier Future
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-162XFrequency: 6 issues/year

Current HIV Research is a pivotal journal dedicated to the latest advancements in the field of HIV research, published by Bentham Science Publishers Ltd. With a commitment to disseminating high-quality research, this journal serves as a critical resource for researchers, healthcare professionals, and students interested in infectious diseases and virology. The journal has an ISSN of 1570-162X and an E-ISSN of 1873-4251, reflecting its commitment to contemporary digital scholarship. Given its publication history spanning from 2003 to 2024, the journal has continually provided insights and peer-reviewed articles that foster knowledge and innovation in HIV research. Although it currently holds a Q3 ranking in Infectious Diseases and a Q4 ranking in Virology, these rankings underscore its importance as an emerging platform for critical research dialogue. Despite not being an Open Access journal, 'Current HIV Research' ensures that cutting-edge studies reach relevant practitioners and contribute to ongoing discourse in the medical community. By fostering an informed approach to HIV and its implications, this journal is an invaluable asset to those committed to advancing their expertise in this crucial area of health science.

Annual Review of Virology

Shaping the future of virology through scholarly excellence.
Publisher: ANNUAL REVIEWSISSN: 2327-056XFrequency: 1 issue/year

Annual Review of Virology is a premier scholarly journal published by Annual Reviews, dedicated to advancing the field of virology through comprehensive and insightful reviews. Since its inception in 2014, this journal has established itself as a leading resource for researchers, professionals, and students alike, achieving an impressive Q1 ranking in the field of Virology and a Scopus rank of #10 out of 80 in its category, placing it in the 88th percentile. The journal features in-depth analyses of the latest developments in virology, encompassing various aspects such as viral pathogenesis, host interactions, and antiviral strategies, thereby catering to a diverse audience seeking the most relevant and cutting-edge information. Although it is not Open Access, Annual Review of Virology remains an indispensable tool for those engaged in virology research, transforming complex findings into accessible knowledge that shapes future investigations and practical applications in the field.

Frontiers in Virology

Shaping the Future of Virology Through Collaboration
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Virology, published by FRONTIERS MEDIA SA, is an innovative open-access journal dedicated to advancing the understanding of viral biology, pathogenesis, surveillance, and control strategies. With the rapid evolution of viral threats, this journal serves as a critical platform for researchers, professionals, and students to disseminate and access high-quality research, reviews, and perspectives in virology. The journal places a strong emphasis on interdisciplinary approaches, promoting collaborative efforts that drive breakthroughs in the field. While the specific impact factor and H-index details are currently unavailable, Frontiers in Virology is committed to rigorous peer review and integrity in scientific publishing. Authors and readers will benefit from the extensive reach provided by open access, making groundbreaking insights available to a global audience, thus contributing significantly to the ongoing dialogue in virology and public health.